Salicyladehyde

Salicyladehyde

SCHEMBL29001196

NNc1ccncn1.O=Cc1ccccc1O

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRIM24 O15164 1/20 0.51
▸ TRIM33 Q9UPN9 1/20 0.51
▸ HTT P42858 4/20 0.38
▸ RAB9A P51151 4/20 0.38
▸ NPC1 O15118 3/20 0.38
▸ L3MBTL1 Q9Y468 3/20 0.38
▸ ERN1 O75460 5/20 0.38
▸ CHRNB2 P17787 1/20 0.37
▸ CHRNB4 P30926 1/20 0.37
▸ CHRNA3 P32297 1/20 0.37
▸ CHRNA4 P43681 1/20 0.37
▸ P2RX7 Q99572 1/20 0.36
▸ CDK4 P11802 1/20 0.36
▸ CCND1 P24385 1/20 0.36
▸ KMT2A Q03164 5/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ LMNA P02545 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Salicyladehyde SCHEMBL28322123 0.84 TRIM24 (0.56) TRIM24TRIM33HTTRAB9ANPC1
Salicyladehyde SCHEMBL28770773 0.84 TRIM24 (0.56) TRIM24TRIM33HTTRAB9ANPC1
5-Bromosalicylaldehyde SCHEMBL28642139 0.81 ERN1 (0.56) HTTRAB9ANPC1L3MBTL1ERN1
SCHEMBL28652613 0.78 ERN1 (0.62) HTTRAB9ANPC1L3MBTL1ERN1
SCHEMBL29001185 0.78 ERN1 (0.59) HTTRAB9ANPC1L3MBTL1ERN1
Salicyladehyde SCHEMBL29001184 0.78 TRIM24 (0.49) TRIM24TRIM33HTTRAB9ANPC1
Salicyladehyde SCHEMBL27772183 0.78 TRIM24 (0.72) TRIM24TRIM33HTTRAB9ANPC1
Benzene SCHEMBL29086472 0.76 HSP90AA1 (0.44) HTTCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL2086404 0.76 — —
Isoniazid SCHEMBL15517690 0.72 KDM4E (0.62) TRIM24TRIM33HTTRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113583028-B High cancer cell selectivity anticancer medicine based on metal organic complex and preparation method thereof 广东石油化工学院 2023-05-12 — — CN disclosed
Send feedback